APA (7th ed.) Citation

M, M., J, S., S, E., L, V., F, I., Z, R., . . . L, P. (2023). Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: Results from the EPICOVIDEHA registry. Therapeutic advances in hematology, 14, 20406207231154706. https://doi.org/10.1177/20406207231154706

Chicago Style (17th ed.) Citation

M, Marchetti, et al. "Outcomes of SARS-CoV-2 Infection in Ph-neg Chronic Myeloproliferative Neoplasms: Results from the EPICOVIDEHA Registry." Therapeutic Advances in Hematology 14 (2023): 20406207231154706. https://doi.org/10.1177/20406207231154706.

MLA (9th ed.) Citation

M, Marchetti, et al. "Outcomes of SARS-CoV-2 Infection in Ph-neg Chronic Myeloproliferative Neoplasms: Results from the EPICOVIDEHA Registry." Therapeutic Advances in Hematology, vol. 14, 2023, p. 20406207231154706, https://doi.org/10.1177/20406207231154706.